An FDA advisory committee will test Otsuka/Lundbeck's use of a Phase II trial as supportive data in PTSD after a Phase III trial failed. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
